← All organizations
Highest phase reached
Phase 4
First clinical trial
Apr 30, 2011Last known activity
Apr 15, 2024
Timeline
1300s
- Jan 1, 1300
Universitat de Lleida— Founded
Drugs by trial phase (10 distinct, 8 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (17)
- NCT06358716Lead sponsorN/AApr 15, 2024
- NCT06358716Sponsor investigatorN/AApr 15, 2024
- NCT06264622Lead sponsorN/AFeb 26, 2024
- NCT06264622Sponsor investigatorN/AFeb 26, 2024
- NCT04801303CollaboratorPhase 4Aug 25, 2021
- NCT04915053Lead sponsorN/AMay 15, 2021
- NCT04915053Reponsible party - principal investigatorN/AMay 15, 2021
- NCT04915053Overall official - principal investigatorN/AMay 15, 2021
- NCT02898610CollaboratorPhase 3Oct 1, 2016
- NCT03888196Lead sponsorEarly Phase 1Sep 1, 2016
- NCT03888196Overall official - principal investigatorEarly Phase 1Sep 1, 2016
- NCT03888196Study directorEarly Phase 1Sep 1, 2016
- NCT03888196Reponsible party - principal investigatorEarly Phase 1Sep 1, 2016
- NCT03888196Study chairEarly Phase 1Sep 1, 2016
- NCT04545463Lead sponsorN/AMay 1, 2015
Details
- Founded
- Lleida, ES Jan 1, 1300
- Last known activity
- Apr 15, 2024